메뉴 건너뛰기




Volumn 45, Issue 8, 2000, Pages 1601-1607

Sequential group trial to determine gastrointestinal site of absorption and systemic exposure of azathioprine

Author keywords

6 mercaptopurine; Azathioprine; Bioavailabili ty; Gastrointestinal; Inflammatory bowel disease; Pharmacokinetics

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE;

EID: 0033831048     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005573229786     Document Type: Article
Times cited : (9)

References (30)
  • 1
    • 0029923360 scopus 로고    scopus 로고
    • A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
    • (1996) Am J Gastroenterol , vol.91 , pp. 423-433
    • Sandborn, W.J.1
  • 5
    • 0016293798 scopus 로고
    • Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial
    • (1974) BMJ , vol.4 , pp. 627-630
    • Jewell, D.P.1    Truelove, S.C.2
  • 30
    • 0025148411 scopus 로고
    • A reversed-phase high-performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a subject receiving thiopurine therapy
    • (1990) Biomed Chromat , vol.4 , pp. 47-51
    • Erdmann, G.R.1    France, L.A.2    Bostrom, B.C.3    Canafax, D.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.